Atlas Trials

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

Clinical trial NCT00725803 · COMPLETED

Trial details

NCT number
NCT00725803
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HCV Infection
Start date
2008-04-01
Primary completion
2008-10-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.